Serum creatine kinase isoenzyme BB in mammalian osteopetrosis.
In mammalian osteopetrosis the different mutations exemplify reduced bone resorption leading to net accumulation of bone. Recently, high blood levels of creatine kinase-BB have been reported in some human forms, suggesting it as a marker of osteopetrosis. In the current study serum creatine kinase-BB was evaluated in relation to known osteoclastic pathophysiology in two human types of autosomal dominant osteopetrosis at baseline and after stimulation with triiodothyronine and in four different rodent mutations. Creatine kinase-BB was increased markedly in Type 2 autosomal dominant osteopetrosis and in the incisors absent rat, both characterized by large numbers of giant osteoclasts, and did not change significantly after stimulation. Although creatine kinase-BB was unchanged in Type 1 autosomal dominant osteopetrosis at baseline and after stimulation, the rodent counterparts characterized by small osteoclasts, microphthalmic and osteopetrotic mice and toothless rats, had significantly decreased levels. Similar differences were observed in both types of autosomal dominant osteopetrosis compared with controls concerning tartrate resistant acid phosphatase. Creatine kinase-BB in mammalian osteopetrosis is related to osteoclastic number and size, where it probably reflects the differentiation and maturation of inactive bone resorbing cells. The isoenzyme does not seem to be a valuable screening marker for osteopetrosis.
Bollerslev
J
J
Department of Medical Endocrinology, National University Hospital, Oslo, Norway.
Ueland
T
T
Landaas
S
S
Marks
S C
SC
D000328:Adult; D000818:Animals; D003402:Creatine Kinase / Q000235:genetics*; D005260:Female; D006801:Humans; D007527:Isoenzymes; D008297:Male; D051379:Mice; D008875:Middle Aged; D009154:Mutation; D010022:Osteopetrosis / Q000201:enzymology* / Q000235:genetics*; D051381:Rats
D007527:Isoenzymes; D003402:Creatine Kinase